TEX41 and acute lymphoblastic leukemia: As shown in Fig. 2 (panel A) the expression levels of TEX41 were significantly higher in B-ALL patients in comparison to PBMCs from healthy subjects, being the median expression level of 3.373*10− 5 at diagnosis to 1.033*10− 6 in healthy donors (Table 3).